These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9336393)

  • 1. Decreased vasodilator response to isoproterenol during nitric oxide inhibition in humans.
    Cardillo C; Kilcoyne CM; Quyyumi AA; Cannon RO; Panza JA
    Hypertension; 1997 Oct; 30(4):918-21. PubMed ID: 9336393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. beta-Adrenoceptor-mediated, nitric-oxide-dependent vasodilatation is abnormal in early hypertension: restoration by L-arginine.
    Schlaich MP; Ahlers BA; Parnell MM; Kaye DM
    J Hypertens; 2004 Oct; 22(10):1917-25. PubMed ID: 15361763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm.
    Lembo G; Iaccarino G; Vecchione C; Barbato E; Izzo R; Fontana D; Trimarco B
    J Clin Invest; 1997 Oct; 100(8):2007-14. PubMed ID: 9329964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective defect in nitric oxide synthesis may explain the impaired endothelium-dependent vasodilation in patients with essential hypertension.
    Cardillo C; Kilcoyne CM; Quyyumi AA; Cannon RO; Panza JA
    Circulation; 1998 Mar; 97(9):851-6. PubMed ID: 9521333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of inhibition of the L-arginine/nitric oxide pathway on vasodilation caused by beta-adrenergic agonists in human forearm.
    Dawes M; Chowienczyk PJ; Ritter JM
    Circulation; 1997 May; 95(9):2293-7. PubMed ID: 9142007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Adrenergic-mediated vasodilation in young men and women: cyclooxygenase restrains nitric oxide synthase.
    Limberg JK; Johansson RE; Peltonen GL; Harrell JW; Kellawan JM; Eldridge MW; Sebranek JJ; Schrage WG
    Am J Physiol Heart Circ Physiol; 2016 Mar; 310(6):H756-64. PubMed ID: 26747505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans.
    Smits P; Williams SB; Lipson DE; Banitt P; Rongen GA; Creager MA
    Circulation; 1995 Oct; 92(8):2135-41. PubMed ID: 7554193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of nitric oxide in the vasodilator response to mental stress in normal subjects.
    Cardillo C; Kilcoyne CM; Quyyumi AA; Cannon RO; Panza JA
    Am J Cardiol; 1997 Oct; 80(8):1070-4. PubMed ID: 9352980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does lipoprotein(a) impair endothelial function?
    Schlaich MP; John S; Langenfeld MR; Lackner KJ; Schmitz G; Schmieder RE
    J Am Coll Cardiol; 1998 Feb; 31(2):359-65. PubMed ID: 9462580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial differences in nitric oxide-mediated vasodilator response to mental stress in the forearm circulation.
    Cardillo C; Kilcoyne CM; Cannon RO; Panza JA
    Hypertension; 1998 Jun; 31(6):1235-9. PubMed ID: 9622135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension.
    Taddei S; Virdis A; Ghiadoni L; Magagna A; Salvetti A
    Hypertension; 1997 Jan; 29(1 Pt 2):274-9. PubMed ID: 9039114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients.
    Casino PR; Kilcoyne CM; Quyyumi AA; Hoeg JM; Panza JA
    Circulation; 1993 Dec; 88(6):2541-7. PubMed ID: 8252665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelium-dependent NO-mediated vasodilation in humans is attenuated by peripheral alpa1-adrenoceptor activation.
    Kamper AM; de Craen AJ; Westendorp RG; Blauw GJ
    Vasc Health Risk Manag; 2005; 1(3):251-6. PubMed ID: 17319111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of nitric oxide in adenosine-induced vasodilation in humans.
    Costa F; Biaggioni I
    Hypertension; 1998 May; 31(5):1061-4. PubMed ID: 9576114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative aspects of the inhibition by N(G)-monomethyl-L-arginine of responses to endothelium-dependent vasodilators in human forearm vasculature.
    Dawes M; Chowienczyk PJ; Ritter JM
    Br J Pharmacol; 2001 Nov; 134(5):939-44. PubMed ID: 11682440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of beta-adrenergic receptor-mediated venodilation in humans.
    Schindler C; Dobrev D; Grossmann M; Francke K; Pittrow D; Kirch W
    Clin Pharmacol Ther; 2004 Jan; 75(1):49-59. PubMed ID: 14749691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway.
    Panza JA; García CE; Kilcoyne CM; Quyyumi AA; Cannon RO
    Circulation; 1995 Mar; 91(6):1732-8. PubMed ID: 7882481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of endothelium-derived nitric oxide to exercise-induced vasodilation.
    Gilligan DM; Panza JA; Kilcoyne CM; Waclawiw MA; Casino PR; Quyyumi AA
    Circulation; 1994 Dec; 90(6):2853-8. PubMed ID: 7994830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective loss of microvascular endothelial function in human hypercholesterolemia.
    Gilligan DM; Guetta V; Panza JA; García CE; Quyyumi AA; Cannon RO
    Circulation; 1994 Jul; 90(1):35-41. PubMed ID: 8026018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bimodal distribution of vasodilator responsiveness to adenosine due to difference in nitric oxide contribution: implications for exercise hyperemia.
    Martin EA; Nicholson WT; Eisenach JH; Charkoudian N; Joyner MJ
    J Appl Physiol (1985); 2006 Aug; 101(2):492-9. PubMed ID: 16614358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.